Clinical Research Directory
Browse clinical research sites, groups, and studies.
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma
Sponsor: The First People's Hospital of Changzhou
Summary
The purpose of this study is to determine whether combining of radiofrequency ablation (RFA) and cytokine-induced killer cells (CIK) transfusion can prolong survival of patients with cholangiocarcinoma.
Official title: Phase III Study of Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma
Key Details
Gender
All
Age Range
30 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2012-07
Completion Date
2033-07
Last Updated
2017-08-01
Healthy Volunteers
No
Conditions
Interventions
Radiofrequency ablation
Radiofrequency ablation is performed percutaneously under CT/US guidance
Cytokine-induced killer cells
The patients received autologous cytokine-induced killer cells transfusion one week after RFA treatment.
Locations (1)
The First People's Hospital of Changzhou
Changzhou, Jiangsu, China